Literature DB >> 11228400

Interleukin-4 reversed the Interleukin-1-inhibited proteoglycan synthesis through the inhibition of NO release: a possible involvement of intracellular calcium ion.

F Nishisaka1, S Sohen, H Fukuoka, Y Okamoto, M Matukawa, K Fukuda, C Hamanishi.   

Abstract

Interleukin-1 (IL-1) causes cartilage degradation through nitric oxide (NO) synthesis. Although Interleukin-4 (IL-4) antagonizes the IL-1-mediated cartilage degradation, the precise mechanisms are not clear. We examined the effect of IL-4 on NO synthesis in parallel with intracellular Ca levels ([Ca(2+)]i) and proteoglycan (PG) synthesis. IL-4-inhibited IL-1-enhanced NO release in a dose-dependent manner. IL-1-enhanced [Ca(2+)]i in the chondrocytes, and IL-4 attenuated this increase. IL-4 reversed IL-1-inhibited PG synthesis. Accordingly, IL-4 reversed the IL-1-inhibited PG synthesis through the inhibition of NO release. An increase in [Ca(2+)]i with IL-1 is possibly involved in this action.

Entities:  

Year:  2001        PMID: 11228400     DOI: 10.1016/s0928-4680(00)00061-4

Source DB:  PubMed          Journal:  Pathophysiology        ISSN: 0928-4680


  3 in total

1.  Interleukin-4 modulates the inflammatory response in ifosfamide-induced hemorrhagic cystitis.

Authors:  Francisco Yuri Bulcão Macedo; Lívia Talita Cajaseiras Mourão; Helano Carioca Freitas; Roberto C P Lima; Deysi Viviana Tenazoa Wong; Reinaldo Barreto Oriá; Mariana L Vale; Gerly Anne Casto Brito; Fernando Q Cunha; Ronaldo A Ribeiro
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

Review 2.  Scorpion venom and the inflammatory response.

Authors:  Vera L Petricevich
Journal:  Mediators Inflamm       Date:  2010-03-14       Impact factor: 4.711

3.  Human osteoarthritic cartilage shows reduced in vivo expression of IL-4, a chondroprotective cytokine that differentially modulates IL-1β-stimulated production of chemokines and matrix-degrading enzymes in vitro.

Authors:  Elisa Assirelli; Lia Pulsatelli; Paolo Dolzani; Daniela Platano; Eleonora Olivotto; Giuseppe Filardo; Giovanni Trisolino; Andrea Facchini; Rosa Maria Borzì; Riccardo Meliconi
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.